Unleash Immuno Oncolytics, Inc.

Biotechnology company · St. Louis, Missouri, United States

Unleash Immuno Oncolytics, Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Unleash Immuno Oncolytics at a glance

Typebiotechnology company

HeadquartersSt. Louis, Missouri, United States

Earliest incorporation on record2015

SEC CIK1732374

What does Unleash Immuno Oncolytics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $3 million sold (2018).

Frequently asked questions about Unleash Immuno Oncolytics

Where is Unleash Immuno Oncolytics headquartered?

Unleash Immuno Oncolytics, Inc. is headquartered in St. Louis, Missouri, United States.

What does Unleash Immuno Oncolytics do?

Unleash Immuno Oncolytics, Inc. is a biotechnology company.

When was Unleash Immuno Oncolytics founded?

The earliest incorporation on record for Unleash Immuno Oncolytics, Inc. is in 2015, according to public company registers.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences